DrugPatentWatch Database Preview
Drugs in Development Information for SP2086
Try a free trial
See Plans and Pricing
Summary for SP2086
| US Patents | 4 |
| International Patents | 47 |
| US Patent Applications | 5 |
| WIPO Patent Applications | 4 |
| Japanese Patent Applications | 0 |
| Clinical Trial Progress | Phase 2 (2013-04-01) |
| Vendors | 4 |
US Patents for SP2086
| Drugname | Patent Number | Patent Title | Patent Assignee | Estimated Expiration |
|---|---|---|---|---|
| SP2086 | ➤ Sign Up | Tetrahydro-imidazo[1,5-.alpha.]pyrazine derivatives, preparation process and medicinal use thereof | Jiangsu Hengrui Medicine Co. Ltd. (Jiangsu, CN) Shanghai Hengrui Pharmaceutical Co. Ltd. (Shanghai, CN) | ➤ Sign Up |
| SP2086 | ➤ Sign Up | Pharmaceutical composition for treatment of type 2 diabetes | Jiangsu Hengrui Medicine Co., Ltd. (Lianyungang, CN) | ➤ Sign Up |
| SP2086 | ➤ Sign Up | Tetrahydro-imidazo[1,5-.alpha.] pyrazine derivatives, preparation process and medicinal use thereof | Jiangsu Hengrui Medicine Co., Ltd. (Jiangsu, CN) | ➤ Sign Up |
| >Drugname | >Patent Number | >Patent Title | >Patent Assignee | >Estimated Expiration |
International Patents for SP2086
| Drugname | Country | Document Number | Estimated Expiration | Related US Patent |
|---|---|---|---|---|
| SP2086 | Australia | 2008342461 | 2027-12-26 | ➤ Sign Up |
| SP2086 | Brazil | PI0821440 | 2027-12-26 | ➤ Sign Up |
| SP2086 | Canada | 2706735 | 2027-12-26 | ➤ Sign Up |
| >Drugname | >Country | >Document Number | >Estimated Expiration | >Related US Patent |
